F2 and blood coagulation disease: Leflunomide-induced hepatotoxicity in humans has been associated with coagulopathy secondary to hepatic synthetic dysfunction, which may manifest as prolonged prothrombin time (PT) and activated partial thromboplastin time (aPTT) (12, 18).